injectable retatrutide Retatrutide: A New Treatment for Weight Management Now offering RETATRUTIDE for weight

As with all GLP-1 therapies, there are important safety considerations: Not suitable for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) May cause nausea, vomiting, diarrhea , especially during dose titration Monitor for signs of pancreatitis , gallbladder issues, or allergic reactions Not indicated for patients with Type 1 diabetes or those with severe gastrointestinal disorders Regular follow-ups, lab monitoring, and dose adjustments are part of the DrWell Methodology to ensure safe, effective outcomes

Evidence in Tobacco Use Disorder In one RCT examining GLP-1 RAs in tobacco use disorder, semaglutide treatment reduced daily cigarette smoking

Lancet 2018;392:2180-93.ArticlePubMed 127

Weeks 1 to 2 Youll learn the movement patterns and find your starting weights

While pancreatitis is uncommon, being vigilant and aware of the signs can help ensure timely intervention and appropriate care if needed

Increasing fiber can ease constipation and limiting fat intake can decrease diarrhea